Trk 受体是三种受体酪氨酸激酶 (TrkA、TrkB 和 TrkC) 的家族,每种激酶都可以被四种神经营养因子中的一种或多种激活:神经生长因子 (NGF)、脑源性神经营养因子 (BDNF) 以及神经营养因子 3 和 4 (NT3 和 NT4)。
TrkA、TrkB 和 TrkC 是跨膜蛋白,构成 TRK 受体家族。这些受体酪氨酸激酶在人类神经组织中表达,并通过神经营养因子 (NT) 的激活在神经系统的生理发育和功能中发挥重要作用。后者是特异性配体,分别为 TrkA 的 NGF、TrkB 的 BDGF、NT-4/5 和 TrkC 的 NT3。
配体与受体的结合触发受体的寡聚化和胞质内激酶域中特定酪氨酸残基的磷酸化。这一事件导致信号转导通路的激活,从而导致正常和肿瘤性神经元细胞的增殖、分化和存活。
Trk receptors are a family of three receptor tyrosine kinases (TrkA, TrkB, and TrkC), each of which can be activated by one or more of four neurotrophins-nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophins 3 and 4 (NT3 and NT4).
TrkA, TrkB, and TrkC are transmembrane proteins that comprise the TRK receptor family. These receptor tyrosine kinases are expressed in human neuronal tissue, and play an essential role in both the physiology of development and function of the nervous system through activation by neurotrophins (NTs). The latter are specific ligands known as NGF for TrkA, BDGF, and NT-4/5 for TrkB and NT3 for TrkC, respectively.
The binding of the ligand to the receptor triggers the oligomerisation of the receptors and phosphorylation of specific tyrosine residues in the intracytoplasmic kinase domain. This event results into the activation of signal transduction pathways leading to proliferation, differentiation and survival in normal and neoplastic neuronal cells.
NTRK1-ligand-1 (Compound 15) 是一种可作为靶蛋白配体 (Ligands for Target Protein for PROTAC) 用于开发设计 PROTAC NTRK1 降解剂(如 PROTAC NTRK1 degrader-1 (MS-J46739))并用于实体肿瘤研究的 NTRK1 配体。
Udonitrectag (REC 0559) 是一种神经生长因子肽模拟物及 TrkA 受体结合剂,可通过结合 TrkA 受体模拟抗凋亡 (Apoptotic) 活性与角膜营养活性,促进角膜上皮与基质的愈合,并可用于神经营养性角膜炎的相关研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号